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 RNA interference (RNAi) mediated by siRNAs has proved to be a highly effective gene silencing
mechanism with great potential for gene therapeutic applications. However, siRNA agents have been
shown to exert non-target-related biological effects and toxicities, including immune stimulation.
Speciﬁcally, siRNA synthesized from a T7 RNA polymerase system can trigger the potent induction
of type I IFN in a variety of cells. The single-stranded RNA can also stimulate innate cytokine
responses in mammals. We found that pppGn (n = 1–3), associated with the 5  end of the shRNA
produced from the T7 RNA polymerase system, did not induce detectable levels of IFN. The residual
amount of G associated with the 5 -end of the transcript was proportional to the reduction of the
interferon response. We describe a T7 pppGn (n = 1–3) shRNA synthesis system that alleviates the
IFN response, which will facilitate the design of siRNAs while maintaining their full efﬁcacy.
Keywords RNAi; shRNA; T7 RNA polymerase; type I interferon
INTRODUCTION
RNAi is a newly described natural biological phenomenon mediated by
siRNA molecules, which target speciﬁc mRNAs for degradation by cellular
enzymes. Surprisingly, recent studies have indicated that siRNAs can induce
global upregulation of the expression of IFN-stimulated genes.[1−5] This
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effect was detected with synthetic siRNAs that were transfected into cells and
with siRNAs that were produced within cells by the expression of shRNAs.
Both of these studies documented signiﬁcant nonspeciﬁc changes in gene
expression as a consequence of the delivery of siRNAs. Two recent stud-
ies have indicated that the mechanism of the IFN response might include
the recognition of the siRNAs by TLR3.[4,6] In addition, long dsRNA and
single-stranded (ss) RNA of ssRNA viruses are detected through TLR7 and
TLR8,[7,8] located in the endosomal membrane.[9] Recently, Kim et al.[10]
showed that siRNAs synthesized using the T7 RNA polymerase system can
trigger the potent induction of IFN-α a n d- ßi nav a r i e t yo fc e l l s .T h em e d i a -
tors of this response revealed that an initiating 5 -triphosphate was required
for IFN induction.
In this study, we describe the absence of interferon induction by an new
type of shRNAs, pppGG-shRNA, synthesized by bacteriophage polymerase.
RESULTS AND DISCUSSION
To investigate the RNAi-mediated silencing of luciferase activity, we ini-
tially synthesized six shRNAs targeting the luciferase gene transcript, us-
ing T7 RNA polymerase. The locations of these targets are provided in
Figure 1. The luc-shRNAs include the 5 -pppGG sequence, because efﬁcient
T7 RNA polymerase initiation requires G as the ﬁrst and second nts of each
RNA. The inhibition of luciferase activity was measured by the DLRTM assay
system. In the DLRTM assay, the ﬁreﬂy and Renilla luciferase activities are
measured sequentially from a single sample. To determine whether pppGG-
luc-shRNAs can speciﬁcally inhibit luciferase gene expression, HeLa CD4+
cells were transfected with the pppGG-luc-shRNAs corresponding to the lu-
ciferase gene, and then were further transfected with pGL3-control (Fireﬂy)
and phRG-TK (Renilla). The six pppGG-luc-shRNAs (luc-1–6) all inhibited
the luciferase activities (data not shown), with luc-3 and 4 showing the most
inhibitory activity.
Recently, Kim et al.[10] showed that siRNAs synthesized using the T7
RNA polymerase system can trigger the potent induction of IFN-α and -ß
in a variety of cells. The mediators of this response revealed that an initiat-
ing 5 -triphosphate was required for IFN induction. To verify the induction
of INF by pppGG-shRNA, we designed pppGn (n = 0–3) associated with
the 5  end of shRNA-luc-3, which was transcribed by T7 RNA polymerase
FIGURE 1 Locations of shRNAs targeting luciferase mRNA.Lack of IFN Response to T7 Transcribed pppG 807
FIGURE 2 Lack of interferon induction by T7-transcribed shRNA. (a) The shRNA-luc constructs
synthesized in these studies. We designed the pppGn (n = 0–3) associated with the 5  end of the
shRNA, which was transcribed by T7 RNA polymerase. We also designed the 5 -HOGn (n = 0–3)
with the 5  end of shRNA (removal of triphosphate by CIP). (b) The anti-luciferase activity of the
pppGn (n = 0–3) associated with the 5  end of shRNA-luc-3 in HeLaCD4+ cells. Fireﬂy and Renilla
luciferase activities were measured consecutively by using dual-luciferase assays (Promega) 48 h af-
ter transfection. (c) The residual amount of G associated with the 5 -end of the transcript is essen-
tial for the lack of interferon induction. HeLaCD4+ cells were transfected with 100 nM of pppGn
(n = 0–3)-shRNAs or HOGn (n = 0–3)-shRNAs. The induced levels of IFN-β were determined by an
ELISA.808 T. Gondai et al.
(Figure 2a). The luc-3 construct induced the inhibition of luciferase activ-
ity in a dose-responsive manner (Figure 2b). However, the control pppGG-
shRNA, targeting EGFP itself, showed no inhibitory effect on the luciferase
activity (Figure 2b). Furthermore, the residual amount of G associated with
the 5 -end of the transcript did not affect the inhibition of the luciferase
activity. On the other hand, we also designed the 5 -HOGn (n = 0–3) at
the 5  end of the shRNA and tested these shRNA for IFN induction (Fig-
ure 2a). We assayed the media from pppGn or 5 -HOGn (n = 0–3)-shRNA
transfected HeLa CD4+ cells for IFN-ß, using an enzyme-linked immunosor-
bent assay (ELISA). Interferon assays from the pppGn (n = 2,3) associated
with 5  end of shRNA revealed no interferon induction in HeLa CD4+cells
(Figure 2c). The interferon response was initiated slightly by the pppGn
(n = 1) associated with the 5  end of the shRNA. The pppGn (n = 0) associ-
ated with the 5  end of the shRNA showed more potent IFN induction than
the pppGn (n = 1) associated with the 5  end of the shRNA. However, no
IFN induction in HeLa CD4+ cells was elicited by the 5 -HOGn (n = 1–3)
(Figure 2c). Furthermore, the inhibition of luciferase activity by pppGn(n
= 0)-luc-shRNA observed in our data (Figure 2b-c) could be partly due to
IFN induction. These results suggest that the residual amount of G associ-
ated with the 5 -end of the transcript was proportional to the reduction of
the IFN response.
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